interaction records 54 assistance programs 55 0 personal data stored
OmniRx › Tools › Generic competition check › Imetelstat Sodium

Generic competition · all medicines · read 12 November 2026

Is there a generic of Imetelstat Sodium, and who makes it?

Imetelstat Sodium appears in 1 dosage-form group in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming. This is the Orange Book's listing, not a forecast.

Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the Orange Book data files, downloaded 12 November 2026.

Not medical advice. This page reports what the FDA's Orange Book lists, not what a pharmacy has in stock, what anything costs, or whether a generic is right for you. Ask your pharmacist or prescriber about your own medicine.
Imetelstat Sodium1 dosage-form group in the Orange Book
0generic makers listed
  1. Imetelstat Sodium appears in 1 dosage-form group in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed.
  2. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming.
  3. Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.

Powder, Intravenous

Brand listed, no generic listed as marketed

Brand listed as marketed: Rytelo. No generic is listed as marketed.

2020202520302035204001brand 2024data datePatent 7494982 listed to expire 27 December 2026Patent 12442000 listed to expire 15 March 2033Patent 9375485 listed to expire 15 March 2033Patent 12171778 listed to expire 16 June 2039Exclusivity ODE-482 to 6 June 2031
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

  • 6 June 2031Exclusivity ODE-482 Rytelo
  • 27 December 2026Patent 7494982 drug substance
  • 15 March 2033Patent 12442000
  • 15 March 2033Patent 9375485
  • 16 June 2039Patent 12171778

US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.

Where can you go from this result?

Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.